Related Experiment Video
Updated: Jul 8, 2026

23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
[The new measures against tuberculosis in Japan]
1Tuberculosis and Infectious Disease Control Division, Health Service Bureau, Ministry of Health Labour and Welfare, Japan.
Kekkaku : [Tuberculosis]
|January 15, 2008
Summary
Tuberculosis (TB) incidence in Japan remains higher than in other developed nations, despite declining rates. Recent legal reforms aim to improve patient care and pathogen management, though TB control remains challenging.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
Context:
- Tuberculosis (TB) incidence in the Western Pacific region was 236 in 2004, with Japan at 23.3.
- Despite a steady decline, Japan's TB rate exceeds that of the UK, USA, and Canada.
- TB affects the elderly and urban populations disproportionately, with outbreaks occurring in healthcare settings and schools.
Purpose:
- To review the epidemiological status of tuberculosis in Japan.
- To analyze recent legislative changes in tuberculosis control policy.
- To assess the ongoing challenges in managing tuberculosis.
Summary:
- Japan's TB incidence, while decreasing, remains a public health concern compared to other high-income countries.
- New legislation integrates TB into infectious disease control, emphasizing pathogen management and isolation for smear-positive cases.
- Policy changes include the adoption of Directly Observed Treatment, Short-course (DOTS) and direct BCG vaccination.
Impact:
- The revised laws aim to improve prompt and proper patient treatment, considering human rights.
- Despite enhanced measures, tuberculosis control continues to be a significant challenge.
- Ongoing efforts are crucial for effective tuberculosis management and prevention.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
